*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.
SmartTRAK reports that In Q319, the WW Trauma Market (defined as fixation of the pelvis, femur & proximal/shaft portion of the tibia) increased +3.7% (as reported), with the US posting +4.6% growth. Q319 WW share leaders remained relatively steady compared to last year, with top trauma player DePuy Synthes, followed by Stryker, Zimmer Biomet and Smith & Nephew. The WW Trauma Market Segment shares were...
Among the many topics covered in the complete, comprehensive Q319 Trauma Market Recap* are:Value-based care has remained a consistent theme in the trauma arena over the last two-plus years and will continue to impact the segment in the future. Manufacturers are being pushed to provide evidence-based data that supports the claims that new products reduce OR time, improve care or lower costs for the surgery center or hospital. Longtime trauma player Smith & Nephew has benefited from...
Read the complete, comprehensive Q319 Trauma Market Recap including news, financial data, charts, company revenues and shares, plus insightful analysis from our team of experts*...
*The entire unedited article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.